The Year of Clinical Trial Diversity

By | June 28, 2016

The FDA's Office of Minority Health has declared 2016 to be "The Year of Clinical Trial Diversity"!

FDA OMH has been developing new resources to help promote diversity in clinical trials. This is important because sometimes minorities may respond differently to medical products. If participation remains low, disparities may continue to exist because of lack of available information about differences in response to treatments- particularly for diseases where minorities are adversely impacted.

They have developed a communications toolkit (see link below) to help you become a "Clinical Trials Champion" in sharing this important message with your community. The attached toolkit contains draft social media messages, sample email/newsletter and blog, and graphics to help promote these efforts.

Commissioner Rob Califf, M.D. dedicated 2016 to improving minority participation in clinical trials. For more information about this initiative, please contact Jovonni Spinner at jovonni.spinner@fda.hhs.gov.

The videos and resources are available here:

Clinical Trials Stakeholder Communications Toolkit_FINAL